BIOAF(BIOAF)
BIOAF
No analyst ratings available
No analyst price targets available for BIOAF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $219,468 | $225,215 | $231,111 | $237,163 | $243,372 | $249,745 | $256,284 | $262,994 |
| Low | $219,468 | $225,215 | $231,111 | $237,163 | $243,372 | $249,745 | $256,284 | $262,994 |
| High | $219,468 | $225,215 | $231,111 | $237,163 | $243,372 | $249,745 | $256,284 | $262,994 |
| EBITDA Avg | $-170,858 | $-175,332 | $-179,922 | $-184,634 | $-189,467 | $-194,429 | $-199,519 | $-204,743 |
| Low | $-170,858 | $-175,332 | $-179,922 | $-184,634 | $-189,467 | $-194,429 | $-199,519 | $-204,743 |
| High | $-170,858 | $-175,332 | $-179,922 | $-184,634 | $-189,467 | $-194,429 | $-199,519 | $-204,743 |
| EBIT Avg | $-171,483 | $-175,973 | $-180,580 | $-185,309 | $-190,161 | $-195,140 | $-200,250 | $-205,492 |
| Low | $-171,483 | $-175,973 | $-180,580 | $-185,309 | $-190,161 | $-195,140 | $-200,250 | $-205,492 |
| High | $-171,483 | $-175,973 | $-180,580 | $-185,309 | $-190,161 | $-195,140 | $-200,250 | $-205,492 |
| Net Income Avg | $-854,855 | $-854,855 | $-2M | $-2M | $-804,669 | $-804,669 | $-804,669 | $-791,166 |
| Low | $-854,855 | $-854,855 | $-2M | $-2M | $-804,669 | $-804,669 | $-804,669 | $-791,166 |
| High | $-854,855 | $-854,855 | $-2M | $-2M | $-804,669 | $-804,669 | $-804,669 | $-791,166 |
| EPS Avg | $-0.01 | $-0.01 | $-0.02 | $-0.02 | $-0.01 | $-0.01 | $-0.01 | $-0.01 |
| Low | $-0.01 | $-0.01 | $-0.02 | $-0.02 | $-0.01 | $-0.01 | $-0.01 | $-0.01 |
| High | $-0.01 | $-0.01 | $-0.02 | $-0.02 | $-0.01 | $-0.01 | $-0.01 | $-0.01 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |